Literature DB >> 32857384

Genetic Lineage Tracing of Non-cardiomyocytes in Mice.

Zhongming Chen1, Jop H van Berlo2,3.   

Abstract

Genetic lineage tracing is accomplished using bi-transgenic mice, where one allele is altered to express Cre recombinase, and another allele encodes a Cre-dependent genetic reporter protein. Once Cre is activated (constitutive or in response to tamoxifen), the marker gene-expressing cells become indelibly labeled by the reporter protein. Therefore, daughter cells derived from labeled cells are permanently labeled even if the marker gene that drove Cre recombinase expression is no longer expressed in these cells. This system is commonly used to label putative progenitor cells and determine the fate of their progeny. Here, we describe the use of c-kit-based genetic lineage-tracing mouse line as an example and discuss caveats for performing these types of experiments.

Entities:  

Keywords:  Differentiation; Genetic lineage-tracing; Progenitor cell; Tamoxifen; Transgenic mice

Mesh:

Substances:

Year:  2021        PMID: 32857384     DOI: 10.1007/978-1-0716-0668-1_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Inducible gene expression and gene modification in transgenic mice.

Authors:  F Jaisser
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

2.  Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice.

Authors:  Clare L Abram; Gray L Roberge; Yongmei Hu; Clifford A Lowell
Journal:  J Immunol Methods       Date:  2014-05-22       Impact factor: 2.303

3.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.

Authors:  R Feil; J Wagner; D Metzger; P Chambon
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

4.  Cleavage-dependent ligation by the FLP recombinase. Characterization of a mutant FLP protein with an alteration in a catalytic amino acid.

Authors:  X D Zhu; P D Sadowski
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

5.  Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice.

Authors:  Konstantinos Anastassiadis; Jun Fu; Christoph Patsch; Shengbiao Hu; Stefanie Weidlich; Kristin Duerschke; Frank Buchholz; Frank Edenhofer; A Francis Stewart
Journal:  Dis Model Mech       Date:  2009-08-19       Impact factor: 5.758

6.  Functional expression of the Flp recombinase in Mycobacterium bovis BCG.

Authors:  Houhui Song; Michael Niederweis
Journal:  Gene       Date:  2007-05-21       Impact factor: 3.688

7.  Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71.

Authors:  Philipp Oberdoerffer; Kevin L Otipoby; Mitsuo Maruyama; Klaus Rajewsky
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

8.  High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi.

Authors:  Peter Hohenstein; Joan Slight; Derya Deniz Ozdemir; Sally F Burn; Rachel Berry; Nicholas D Hastie
Journal:  Pathogenetics       Date:  2008-11-03

9.  Strategies for designing transgenic DNA constructs.

Authors:  Chengyu Liu
Journal:  Methods Mol Biol       Date:  2013

10.  c-kit+ cells minimally contribute cardiomyocytes to the heart.

Authors:  Jop H van Berlo; Onur Kanisicak; Marjorie Maillet; Ronald J Vagnozzi; Jason Karch; Suh-Chin J Lin; Ryan C Middleton; Eduardo Marbán; Jeffery D Molkentin
Journal:  Nature       Date:  2014-05-07       Impact factor: 49.962

View more
  1 in total

1.  A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration.

Authors:  Andrea Raso; Ellen Dirkx; Vasco Sampaio-Pinto; Hamid El Azzouzi; Ryan J Cubero; Daniel W Sorensen; Lara Ottaviani; Servé Olieslagers; Manon M Huibers; Roel de Weger; Sailay Siddiqi; Silvia Moimas; Consuelo Torrini; Lorena Zentillin; Luca Braga; Diana S Nascimento; Paula A da Costa Martins; Jop H van Berlo; Serena Zacchigna; Mauro Giacca; Leon J De Windt
Journal:  Nat Commun       Date:  2021-08-10       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.